Efficacy and Safety of the Novel HER3 Directed Antibody Drug Conjugate Patritumab Deruxtecan (HER3-DXd; U3-1402) in EGFR-mutated NSCLC

Yu, H; Baik, C; Gold, K; Hayashi, H; Johnson, M; Koczywas, M; Murakami, H; Nishio, M; Steuer, C; Su, W; Yang, JC; Karam, S; Qi, Z; Qiu, Y; Chen, S; Yu, C; Janne, P

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (3): S107